Market Access and HTA

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity:

The Associate Director, Market Access and HTA, is responsible for leading end-to-end reimbursement activities to ensure timely, sustainable patient access to innovative oncology therapies. Working closely with the Senior Director, Market Access, this role involves delivering high-quality HTA submissions (NICE, SMC, NCPE), supporting the development of Market Access strategies, core pricing and access deliverables, and guiding evidence generation to support value propositions.

The incumbent will partner with global, regional, and local cross functional colleagues, spanning market access, commercial, medical affairs, HEOR and vendor partners on all reimbursement activities by providing access insights, developing evidence-based HTA dossiers and tools, as well as participating in pricing strategy activities.

HTA Strategy and Delivery

• Lead HTA submissions to NICE, SMC, and NCPE from initiation to final recommendation, managing timelines and deliverables.

• Lead engagement with HTA agencies throughout the reimbursement process.

• Source, interpret and generate clinical and economic evidence to support robust submissions.

• Partner with regional and global HEOR teams to support the design and development of health economic models; manage technical vendors as required.

• Communicate complex economic concepts clearly to both technical and non technical audiences.

• Provide expertise on RWE studies, economic modelling, evidence synthesis (SLRs, NMAs, ITCs), and pricing activities.

• Identify and mitigate areas of uncertainty to optimise the likelihood of positive HTA outcomes.

• Monitor health policy developments, HTA processes and local reimbursement environments to inform strategy.

• Build and maintain strong internal and external networks across the HTA, HEOR, and market access community.

Market Access

• Support the Senior Director for Market Access, UK & Ireland in the development of Market Access strategies and development and execution of payer negotiation.

• Contribute to the execution of pricing and access strategies, including the localisation of access strategy, tactical execution and pricing business cases.

• Collaborate with internal functions to develop innovative pricing models to optimize the acceleration of reimbursement approvals.

• Participate in early access planning of new products and indications, drive launch readiness for multiple oncology assets.

• Partner with medical, commercial, regional and global HEOR teams to align evidence generation with market access strategy.

• Work with Global and EU Region Market Access teams to align local access strategy with broader European and corporate objectives, especially in terms of aligning the European/UK regulatory and JCA strategy and execution with local value dossier submission and access and pricing strategies.

• Contribute to access and value related projects such as landscape assessments, payer advisory boards and general guidance on local strategies.

Required Skills, Experience and Education:

• Postgraduate degree in Health Economics, Outcomes Research, or related field.

• 8+ years experience in market access, pricing, reimbursement or health economics (pharma/biotech/market access consulting).

• Experience of involvement in HTA submissions with at least 1 recent NICE and SMC submission (within last 12 months). In-depth HEOR technical expertise and experience.

• Proven experience developing HTA and market access strategies, ideally in oncology.

• Strong understanding of the UK and Ireland healthcare landscape.

• Ability to think strategically and make sound pricing and market access insights/recommendations.

• Strong stakeholder management and ability to collaborate with internal and external partners.

• Excellent communication skills, both in person and virtual.

• Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.

• Willingness to travel nationally and internationally.

• Demonstrated success in small but fast growing, entrepreneurial commercial environment.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.

#LI-LO1 #LI-Hybrid

We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
 
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
 
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.